Citations

Showing 10 of 108094 citations.

Axillary Ultrasound Identifies Residual Nodal Disease After Chemotherapy: Results From the American College of Surgeons Oncology Group Z1071 Trial (Alliance)
Le‐Petross, Huong T. , McCall, Linda, Ahrendt, Gretchen , Wilke, Lee G., Wilke, Lee G. , Hunt, Kelly K. , Mittendorf, EA , Ballman, Karla V. , Boughey, Judy C.

Mayo Clinic

American Journal of Roentgenology | January 30, 2018 | Volume: 210 | Issue: 3 | Pages: 669-676

10.2214/ajr.17.18295 | PMID 29381381 Get It

Common Genetic Variation and Breast Cancer Risk—Past, Present, and Future
Lilyquist, Jenna , Ruddy, Kathryn J. , Vachon, Celine M. , Vachon, Celine M. , Couch, Fergus J.

Mayo Clinic

Cancer Epidemiology, Biomarkers & Prevention | January 30, 2018 | Volume: 27 | Issue: 4 | Pages: 380-394

10.1158/1055-9965.epi-17-1144 | PMID 29382703 Get It

Abstract Breast cancer is the most common cancer among women in the United States, with up to 30% of those diagnosed displaying a family history of breast cancer. To date, 18% of the familial risk of breast cancer can be explained by SNPs. This review summarizes the discovery of risk-associated SNPs using candidate gene and genome-wide association studies (GWAS), including discovery and replication in large collaborative efforts such as The Collaborative Oncologic Gene-environment Study and OncoArray. We discuss the evolution of GWAS studies, efforts to discover additional SNPs, and methods for identifying causal variants. We summarize findings associated with overall breast cancer, pathologic subtypes, and mutation carriers (BRCA1, BRCA2, and CHEK2). In addition, we summarize the development of polygenic risk scores (PRS) using the risk-associated SNPs and show how PRS can contribute to estimation of individual risks for developing breast cancer. Cancer Epidemiol Biomarkers Prev; 27(4); 380–94. ©2018 AACR. See all articles in this CEBP Focus section, “Genome-Wide Association Studies in Cancer.”
Pharmacogenomic Impact of CYP2C19 Variation on Clopidogrel Therapy in Precision Cardiovascular Medicine
Brown, Sherry‐Ann , Pereira, Naveen L.

Mayo Clinic

Journal of Personalized Medicine | January 30, 2018 | Volume: 8 | Issue: 1 | Pages: 8

10.3390/jpm8010008 | PMID 29385765 Get It

Variability in response to antiplatelet therapy can be explained in part by pharmacogenomics, particularly of the CYP450 enzyme encoded by CYP2C19. Loss-of-function and gain-of-function variants help explain these interindividual differences. Individuals may carry multiple variants, with linkage disequilibrium noted among some alleles. In the current pharmacogenomics era, genomic variation in CYP2C19 has led to the definition of pharmacokinetic phenotypes for response to antiplatelet therapy, in particular, clopidogrel. Individuals may be classified as poor, intermediate, extensive, or ultrarapid metabolizers, based on whether they carry wild type or polymorphic CYP2C19 alleles. Variant alleles differentially impact platelet reactivity, concentration of plasma clopidogrel metabolites, and clinical outcomes. Interestingly, response to clopidogrel appears to be modulated by additional factors, such as sociodemographic characteristics, risk factors for ischemic heart disease, and drug-drug interactions. Furthermore, systems medicine studies suggest that a broader approach may be required to adequately assess, predict, preempt, and manage variation in antiplatelet response. Transcriptomics, epigenomics, exposomics, miRNAomics, proteomics, metabolomics, microbiomics, and mathematical, computational, and molecular modeling should be integrated with pharmacogenomics for enhanced prediction and individualized care. In this review of pharmacogenomic variation of CYP450, a systems medicine approach is described for tailoring antiplatelet therapy in clinical practice of precision cardiovascular medicine.
Probing the striatal dopamine system for a putative neuroprotective effect of deep brain stimulation in Parkinson's disease
Ouyang, Bichun , Verhagen, Leo, Shill, Holly A. , Adler, Charles H. , Beach, Thomas G. , Kordower, Jeffrey H. , AZSAND, the, Adler, C H , Pal, Gian D. , Serrano, Geidy E. , AZSAND, the

Mayo Clinic

Movement Disorders | January 30, 2018 | Volume: 33 | Issue: 4 | Pages: 652-654

10.1002/mds.27280 | PMID 29380902 Get It

“Isolated” Suprascapular Neuropathy: Compression, Traction, or Inflammation?
Maldonado, Andrés A. , Howe, Benjamin M. , Mauermann, Michelle L. , Spinner, Robert J. , Le Hanneur, Malo, Mauermann, Michelle L , Hanneur, Malo Le , Maldonado, Andres A.

Mayo Clinic

Neurosurgery | January 30, 2018 | Volume: 84 | Issue: 2 | Pages: 404-412

10.1093/neuros/nyy050 | PMID 29529303 Get It

Abstract BACKGROUND Several hypotheses have been proposed for the pathophysiology of suprascapular nerve (SSN) palsy, including compression, traction, and nerve inflammation. OBJECTIVE To provide insight into the pathophysiology of isolated nontraumatic SSN palsy by performing critical reinterpretations of electrodiagnostic (EDX) studies and magnetic resonance (MR) images of patients with such diagnosis. METHODS We retrospectively reviewed all patients referred to our institution for the past 20 yr with a diagnosis of nontraumatic isolated suprascapular neuropathy who had an upper extremity EDX study and a shoulder or brachial plexus MR scan. Patient charts were reviewed to analyze their initial clinical examination, and their original EDX study and MR images were reinterpreted by an experienced neurologist and a musculoskeletal radiologist, respectively, both blinded from the authors’ hypothesis and from each other's findings. RESULTS Fifty-nine patients were included. Fifty of them (85%) presented with at least 1 finding that was inconsistent with an isolated SSN palsy. Forty patients (68%) had signs on physical examination beyond the SSN distribution. Thirty-one patients (53%) had abnormalities on their EDX studies not related to the SSN. Twenty-two patients (37%) had denervation atrophy in other muscles than the spinati, or neural hyperintensity in other nerves than the SSN on their MR scans, without any evidence of SSN extrinsic compression. CONCLUSION The great majority of patients with presumed isolated SSN palsy had clinical, electrophysiological, and/or imaging evidence of a more diffuse pattern of neuromuscular involvement. These data strongly support an inflammatory pathophysiology in many cases of “isolated” SSN palsy.
Statins decrease leptin expression in human white adipocytes
Singh, Prachi , Zhang, Yuebo , Covassin, Naima , Souček, Filip, Friedman, Paul A. , Sharma, Pragya, Sharma, Pragya , Somers, Virend K. , Singh, Prachi

Mayo Clinic

Physiological Reports | January 30, 2018 | Volume: 6 | Issue: 2 | Pages: e13566

10.14814/phy2.13566 | PMID 29372612 Get It

The influence of pulmonary vascular pressures on lung diffusing capacity during incremental exercise in healthy aging
Coffman, Kirsten E. , Curry, Timothy B. , Dietz, Niki M., Chase, Steven C. , Carlson, Alex R. , Ziegler, Briana, Johnson, Bruce D. , Ziegler, Briana L

Mayo Clinic

Physiological Reports | January 30, 2018 | Volume: 6 | Issue: 2 | Pages: e13565

10.14814/phy2.13565 | PMID 29368799 Get It

Hemispheric asymmetries in the orientation and location of the lateral geniculate nucleus in dyslexia
Giraldo‐Chica, Mónica , Schneider, Keith A.

Mayo Clinic

Dyslexia | January 30, 2018 | Volume: 24 | Issue: 2 | Pages: 197-203

10.1002/dys.1580 | PMID 29380470 Get It

Human brain asymmetry reflects normal specialization of functional roles and may derive from evolutionary, hereditary, developmental, experiential, and pathological factors (Toga & Thompson, 2003). Geschwind and Galaburda (1985) suggested that processing difficulties in dyslexia are due to structural differences between hemispheres. Because of its potential significance to the controversial magnocellular theory of dyslexia, we investigated hemispheric differences in the human lateral geniculate nucleus (LGN), the primary visual relay and control nucleus in the thalamus, in subjects with dyslexia compared to normal readers. We acquired and averaged multiple high‐resolution proton density (PD) weighted structural magnetic resonance imaging (MRI) volumes to measure in detail the anatomical boundaries of the LGN in each hemisphere. We observed hemispheric asymmetries in the orientation of the nucleus in subjects with dyslexia that were absent in controls. We also found differences in the location of the LGN between hemispheres in controls but not in subjects with dyslexia. Neither the precise anatomical differences in the LGN nor their functional consequences are known, nor is it clear whether the differences might be causes or effects of dyslexia.
Oncologic outcomes of extended neck dissections in human papillomavirus‐related oropharyngeal squamous cell carcinoma
Zenga, Joseph , Pipkorn, Patrik , Graboyes, Evan M. , Martin, Eliot J., Rich, Jason T. , Moore, Eric J. , Haughey, Bruce H. , Jackson, Ryan S.

Mayo Clinic

Head & Neck | January 29, 2018 | Volume: 40 | Issue: 5 | Pages: 955-962

10.1002/hed.25060 | PMID 29377416 Get It

AbstractBackgroundOncologic outcomes of human papillomavirus (HPV)‐related oropharyngeal squamous cell carcinoma (SCC) requiring resection of major muscular or neurovascular tissue during neck dissection for invasive nodal disease remain uncertain.MethodsPatients with HPV‐related oropharyngeal SCC requiring resection of major muscular or neurovascular tissue during their neck dissections were retrospectively identified.ResultsSeventy‐two patients were included. Regional and distant recurrences occurred in 6% and 17% of patients. Advanced T classification, pathological node number of 5 or more, and omission of adjuvant therapy were associated with decreased disease‐free survival (DFS). The addition of adjuvant chemotherapy was not associated with improved survival.ConclusionPatients with invasive nodal disease from HPV‐related oropharyngeal SCC can be managed with up‐front surgery and adjuvant therapy, as indicated with good regional control. Although distant recurrence was the primary site of failure, adjuvant chemotherapy was not associated with improved outcomes. The T classification, node number, and adjuvant radiotherapy are independent prognostic factors in this patient population.
Platelet‐predominate gene expression and reticulated platelets in nonvalvular atrial fibrillation: Effect of pulmonary veins isolation
Wysokiński, Waldemar E. , Tafur, Alfonso , Wu, Yanhong , Ammash, Naser M., Asirvatham, Samuel J. , Gosk−Bierska, Izabela , Grill, Diane E. , Slusser, Joshua P. , Mruk, Jozef S., McBane, Robert D. , Ammash, Naser, Wysokinski, Waldemar , McBane, Robert , Asirvatham, Samuel J

Mayo Clinic

Journal of Cardiovascular Electrophysiology | January 29, 2018 | Volume: 29 | Issue: 3 | Pages: 412-420

10.1111/jce.13438 | PMID 29377394 Get It

AbstractIntroductionReticulated platelet (RP) content is increased in nonvalvular atrial fibrillation (NVAF). The purpose of this study was to determine if platelet content, morphology, and RP proportion are modulated by platelet genes.Methods and resultsExpression of six platelet‐predominate genes impacting platelet formation and release, platelet count, and RP content was assessed in NVAF patients before and 3–4 months after pulmonary veins isolation (PVI) and compared to normal sinus rhythm (NSR) controls. RNA from isolated platelets was reverse‐transcribed assayed against selected genes utilizing real‐time qPCR, and expressed as mean cycle threshold (ΔCt) using beta‐2‐microglobulin as endogenous control. RP content was assessed by flow cytometry. A fourfold lower expression of CFL1 gene coding for nonmuscle cofilin (7.8 ± 0.9 vs. 5.7 ± 1.6, P < 0.001) and twofold lower expression of four other genes were associated with similar platelet counts but fourfold higher (28.7+7.0 vs. 6.7+5.4, P < 0.001) RP content (%) in 97 NVAF cases compared to 51 NSR controls. Three to 4 months after PVI, RP decreased by 28%, while CFL1 gene expression increased over twofold but TUBA4A gene expression decreased almost twofold; NFE2 and MYL6 gene expression remained unchanged.ConclusionsNVAF is associated with notable downregulation of genes directing platelet production and size but increased RP content. PVI impacts the expression of many of these genes, implying a direct relationship between atrial fibrillation and platelet biogenesis.